72
Views
40
CrossRef citations to date
0
Altmetric
Research Article

The Role of Complement in Pregnancy and Fetal Loss

&
Pages 19-26 | Published online: 07 Jul 2009

  • Mills, J.L., Simpson, J.L., Driscoll, S.G., Jovanovic-Peterson, L., Van Allen, M., Aarons, J.H., Metzger, B., Bieber, F.R., Knopp, R.H., Holmes, L.B., et al. (1988) "Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception", N. Engl. J. Med. 319, 1617-1623.
  • Hill, J.A. (1992) "Immunological contributions to recurrent pregnancy loss", Bailliere's Clin. Obstet. Gynecol. 6, 489-505.
  • Schmidt, B.Z. and Colten, H.R. (2000) "Complement: a critical test of its biological importance", Immunol. Rev. 178, 166-176.
  • Abbas, A.K., Lichtman, A.H. and Pober, J.S. (2000) "Effector mechanisms of humoral immunity", Cellular and Molecular Immunology, 4th Ed. (W.B. Saunders Company, Philadelphia, PA), pp. 316-334.
  • Weiser, M.R., Williams, J.P., Moore, F.D., Kobzik, L., Ma, M., Hechtman, H.B. and Carroll, M.C. (1996) "Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement", J. Exp. Med. 183, 2343-2348.
  • Korb, L.C. and Ahearn, J.M. (1997) "CIq binds directly and specifically to surface blebs of apoptotic human keratinocytes", J. Immunol. 158, 4525-4528.
  • Mevorach, D., Mascarenhas, J.O., Gershov, D. and Elkon, K.B. (1999) "Complement-dependent clearance of apoptotic cells by human macrophages", J. Exp. Med. 188, 2313-2320.
  • Fearon, D.T. and Locksley, R.M. (1996) "The instructive role of innate immunity in the acquired immune response", Science 272,50-54.
  • Hugli, T.E. (1989) "Structure and function of C3a anaphylatoxin", Curr. Top. Microbiol. Immunol. 153, 181-208.
  • Brown, E.J. (1991) "Complement receptors and phagocytosis", Curr. Opin. Immunol. 3, 76-82.
  • Holers, V.M. (1995) In: Rich, R., ed, Complement, Principles and Practices of Clinical Immunology (Mosby, St. Louis, MO).
  • Gerard, N.P. and Gerard, C. (1991) "The chemotactic receptor for human C5a anaphylatoxin", Nature 349, 614-617.
  • Wetsel, R.A. (1995) "Structure, function and cellular expression of complement anaphylatoxin receptors", Curr. Opin, Immunol. 7, 48-53.
  • Shin, M.L., Rus, H.G. and Nicolescu, F.I. (1996) "Membrane attack by complement: assembly and biology of terminal complement complexes", Biomembranes 4, 123-149.
  • Morgan, B.P. and Meri, S. (1994) "Membrane proteins that protect against complement lysis", Springer Semin. Immunopathol. 15, 369-396.
  • Carroll, M.C. (1998) "The role of complement and complement receptors in the induction and regulation of immunity", Ann. Rev. Immunol. 16, 545-568.
  • Foreman, K.E., Vaporciyan, A.A., Bonish, B.K., Jones, M.L., Johnson, K.J., Glovsky, M.M., Eddy, S.M. and Ward, P.A. (1994) "C5a-induced expression of P-selectin in endothelial cells", J. Clin. Investig. 94, 1147-1155.
  • Morgan, B.P. (1992) "Effects of the membrane attack complex of complement on nucleated cells", Curr. Top. Micmbiol. Immunol. 178,115-140.
  • Benzaquen, L.R., Nicholson-Weller, A. and Halperin, J.A. (1994) 'Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells", J. Exp. Med. 179, 985-992.
  • Hattori, R., Hamilton, K.K., McEver, R.P. and Sims, P.J. (1989) "Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface", J. Biol. Chem. 264, 9053-9060.
  • Devine, D.V. (1992) "The effects of complement activation on platelets", Curr. Top. Microbiol. Immunol. 178, 101-113.
  • Manzi, S., Rairie, J.E., Carpenter, A.B., Kelly, R.H., Jagarlapudi, S.P., Sereika, S.M., Medsger, T.A., Jr. and Ramsey-Goldman, R. (1996) "Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity", Arthritis Rheum. 39, 1178-1188.
  • Hourcade, D., Holers, V.M. and Atkinson, J.P. (1989) "The regulators of complement activation (RCA) gene cluster", Adv. Immunol. 45, 381-416.
  • Lublin, D.M. and Atkinson, J.P. (1989) "Decay-accelerating factor and membrane cofactor protein", Curr. Top. Micmbiol. Immunol. 153, 123-145.
  • Molina, H., Wong, W., Kinoshita, T., Brenner, C., Foley, S. and Holers, V.M. (1992) "Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1", J. Exp. Med. 175, 121-129.
  • Kim, Y.U., Kinoshita, T., Molina, H., Hourcade, D., Tsukasa, S., Wagner, L.M. and Holers, V.M. (1995) "Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein", J. Exp. Med. 181, 151-159.
  • Raghupathy, R. (2001) "Pregnancy: success and failure within the Th1/Th2/Th3 paradigm", Semin. Immunol. 13, 219-227.
  • Vince, G.S. and Johnson, P.M. (1995) "Materno-fetal immunobiology in normal pregnancy and its possible failure in recurrent spontaneous abortion?", Hum. Reprod. 10, 107-113.
  • MeIlor, A.L. and Munn, D.H. (2000) "Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression", Ann. Rev. Immunol. 18, 367-391.
  • Lu, G.C. and Goldenberg, R.L. (2000) "Current concepts on the pathogenesis and markers of pre-term births", Clin. Perinatal. 27, 263-283.
  • Denison, F.C., Kelly, R.W., Calder, A.A. and Riley, S.C. (1998) "Cytokine secretion by human fetal membranes, decidua and placenta at term", Hum. Reprod. 13, 3560-3565.
  • Weetman, A.P. (1999) "The immunology of pregnancy", Thyroid 9, 643-646.
  • Steinborn, A., Niederhut, A., Solbach, C., Hildenbrand, R., Sohn, C. and Kaufmann, M. (1999) "Cytokine release from placental endothelial cells, a process associated with pre-term labour in the absence of intrauterine infection", Cytokine 11, 66-73.
  • Chaouat, G., Menu, E., Clark, D.A., Minkowsky, M., Dy, M. and Wegmann, T.G. (1990) "Control of fetal survival in CBAxDBA/2 mice by lymphokine therapy", J. Reprod. Fertil. 89, 447-458.
  • Amigo, M.C. and Khamashta, M.A. (2000) "Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus", Rheum. Dis. Clin. N. Am. 26, 331-348.
  • Holmes, C.H. and Simpson, K.L. (1992) "Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship", Bailliere's Clin. Obstet. Gynecol. 6, 439-459.
  • Rooney, I.A., Oglesby, T.I. and Atkinson, I.P. (1993) "Complement in human reproduction", Activation Control Immunol. Res. 12, 276-294.
  • Weir, P.E. (1981) "Immunofluorescent studies of the uteroplacental arteries in normal pregnancy", Br. J. Obstet. Gynaecol 88, 301-307.
  • Wells, M., Bennett, J., Bulmer, J.N., Jackson, P. and Holgate, C.S. (1987) "Complement component deposition in uteroplacental (spiral) arteries in normal human pregnancy", J. Reprod. Immunol. 12, 125-135.
  • Cunningham, D.S. and Tichenor, J.R. (1995) "Decay-accelerating factor protects human trophoblast from complement-mediated attack", Clin. Immunol. Immunopathol. 74, 156-161.
  • Tedesco, F., Narchi, G., Radillo, O., Meri, S., Femme, S. and Betterle, C. (1993) "Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins",J. Immunol. 151, 1562-1570.
  • Liszewski, M.K., Farries, T.C., Lublin, D.M., Rooney, I.A. and Atkinson, J.P. (1996) "Control of the complement system", Adv. Immunol. 61, 201-283.
  • Holers, V.M., Kinoshita, T. and Molina, H. (1992) "The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function", Immunol. Today 13, 231-236.
  • Oglesby, T.J., Allen, C.J., Liszewski, M.K., White, D.J. and Atkinson, J.P. (1992) "Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism", J. Exp. Med. 175, 1547-1551.
  • Imrie, H.J., McGonigle, T.P., Liu, D.T. and Jones, D.R. (1996) "Regulation of erythrocyte complement receptor 1 (CR1) and decay accelerating factor during normal pregnancy", J. Reprod. Immunol. 31,221-227.
  • Abramson, S.B. and Buyon, J.P. (1992) "Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy", Am. J. Rep. Med. 28, 183-187.
  • Sinha, D., Wells, M. and FaIk, W.P. (1984) "Immunological studies of human placentas: complement components in pre-eclamptic chorionic villi", Clin. Exp. Immunol. 56, 175-184.
  • Xu, C., Mao, D., Holers, V.M., Palanca, B., Cheng, A. and Molina, H. (2000) "A critical role for the murine complement regulator Crry in fetomaternal tolerance", Science 287, 498-501.
  • Holmes, C.H., Simpson, K.L., Wainwright, S.D., Tate, C.G., Houliham, J.M. and Sawyer, I.H. (1990) "Preferential expression of complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy", J. Immunol. 144, 3099-3105.
  • Holmes, C.H., Simpson, K.L., Okada, H., Okada, N., Wainwright, S.D. and Purcell, D.F. (1992) "Complement regulatory proteins at the fetomaternal interface during human placenta! development distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating (CD55)", Eur. J. Immunol. 22, 1579-1585.
  • Hasty, L.A., Lambris, J.D., Lessey, B.A., Pruksananonda, K. and Lyttle, C.R. (1994) "Hormonal regulation of complement components and receptors throughout the menstrual cycle", Am. J. Obstet. Gynecol 170, 168-175.
  • Wilson, W.A., Gharavi, A.E., Koike, T., Lockshin, M.D., Branch, D.W., Piette, J.C., Brey, R., Derksen, R., Harris, E.N., Hughes, G.R., Triplett, D.A. and Khamashta, M.A. (1999) "International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome", Arthritis Rheum. 42, 1309-1311.
  • Lockshin, M.D., Sammaritano, L.S. and Schwartzman, S.S. (2000) "Validation of the Sapporo criteria for antiphospholipid antibody syndrome", Arthritis Rheum. 43, 440-443.
  • Kaleli, K., Kaleli, I., Aktan, E., Turan, C. and Aksit, F. (1998) "Antiphospholipid antibodies in preeeclamptic women", Gynecol. Obstet. Investig. 45, 81-84.
  • Kutteh, W.H. (1996) "Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone", Am. J. Obstet. Gynecol. 174, 1584-1589.
  • Rai, R., Cohen, H., Dave, M. and Regan, L. (1997) "Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies", J. Br. Med. 314, 253-257.
  • Clifford, K., Rai, R., Watson, H. and Regan, L. (1994) "An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases", Hum. Reprod. 9, 1328-1332.
  • Pattison, N.S., Chamley, L.W., Birdsall, M., Zanderigo, A.M., Liddell, H.S. and McDougall, I. (2000) "Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial", Am. J. Obstet. Gynecol. 183, 1008-1012.
  • Stephenson, M.D. (1996) "Frequency of factors associated with habitual abortion in 197 couples", Fertil. Steril 66, 24-29.
  • Yetman, D.L. and Kutteh, W.H. (1996) "Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies", Fertil. Steril. 66, 540-546.
  • Holers, V.M., Girardi, G., Mo, L., Guthridge, J.M., Molina, H., Pierangeli, S.S., Espinola, R., Xiaowei, L.E., Mao, D., Vialpando, C.G. and Salmon, J.E. (2002) "Complement C3 activation is required for anti-phospholipid antibody-induced fetal loss", J. Exp. Med. 195,211-220.
  • Mellor, A.L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D. and Munn, D.H. (2001) "Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy", Nat. Immunol. 2, 64-68.
  • Munn, D.H., Zhou, M., Attwood, J.T., Bondaev, I., Conway, S.J., Marshall, B., Brown, C. and Mellor, A.L. (1998) "Prevention of allogenic fetal rejection by tryptophan catabolism", Science 281, 1191-1193.
  • Mellor, A.L. and Munn, D.A. (2001) 'Tryptophan catabolism prevents maternal T cells from activation lethal anti-fetal immune responses", J. Reprod. Immunol. 52, 5-13.
  • Schwaeble, W.J. and Reid, K.B.M. (1999) "Does properdin crosslink the cellular and the humoral immune response?", Immunol. Today 18, 17-21.
  • Sheerin, N.S., Zhou, W., Adler, S. and Sacks, S.H. (1997) "TNF-a regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells", Kidney Int. 51,703-710.
  • Terui, T., Ishii, K., Ozawa, M., Tabat, N., Kato, T. and Tagami, H. (1997) "C3 production of cultured human epidermal keratinocytes is enhanced by IFN-? and TNF-a through different pathways", J. Investig. Dermatol. 108, 62-67.
  • Cocuzzi, E.T., Bardenstein, D.S., Stavitsky, A., Sundarraj, N. and Medof, M.E. (2001) "Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differenrial effects of TNF-ß and TNF-a", Curr. Eye Res. 23, 86-89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.